Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated Sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated Sarcoma

Published:2021-01 Issue:5 Volume: Page:1-5
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Doshi Sahil D.¹,Oza Jay²,Remotti Helen³,Remotti Fabrizio³,Moy Matthew P.⁴,Schwartz Gary K.²,Ingham Matthew²

Affiliation:

1. Department of Medicine, Columbia University Irving Medical Center, New York, NY

2. Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY

3. Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY

4. Department of Radiology, Columbia University Irving Medical Center, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00201

Reference22 articles.

1. Sclerosing Epithelioid Fibrosarcoma

2. Fibrosarcoma: a review and update

3. Sclerosing Epithelioid Fibrosarcoma

4. Recurrent EWSR1-CREB3L1 Gene Fusions in Sclerosing Epithelioid Fibrosarcoma

5. Sclerosing Epithelioid Fibrosarcoma: Case Presentation and a Systematic Review

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spontaneous remission of a pulmonary sclerosing epithelioid fibrosarcoma: a case report of a possible abscopal effect;Translational Cancer Research;2024-05

2. Sclerosing Epithelioid Fibrosarcoma;Surgical Pathology Clinics;2024-03

3. Response to Immunotherapy in Sclerosing Epithelioid Fibrosarcoma: Case Report and Literature Review;Cureus;2023-12-22

4. Exploring the landscape of immunotherapy approaches in sarcomas;Frontiers in Oncology;2023-01-09

5. Immunotherapy approaches for rare pediatric solid tumors: advances and future directions;Current Opinion in Pediatrics;2022-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3